Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

as grindeks - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and sitagliptin

Union européenne - lituanien - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Union européenne - lituanien - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ir 5. 1, jei yra duomenų apie skirtingus derinius).

Union européenne - lituanien - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

teva pharma b.v. - levodopa/karbidopa/entakaponas - plėvele dengtos tabletės - 75 mg/18,75 mg/200 mg; 200 mg/50 mg/200 mg; 150 mg/37,5 mg/200 mg; 125 mg/31,25 mg/200 mg; 100 mg/25 mg/200 mg; 50 mg/12,5 mg/200 mg; 75 mg/18,75 mg/20 - levodopa, decarboxylase inhibitor and comt inhibitor

Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

stada arzneimittel ag - losartano kalio druska/hidrochlorotiazidas - plėvele dengtos tabletės - 50 mg/12,5 mg - losartan and diuretics

Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

actavis group ptc ehf. - losartanas/hidrochlorotiazidas - plėvele dengtos tabletės - 50 mg/12,5 mg; 100 mg/25 mg - losartan and diuretics

Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

accord healthcare b.v. - sildenafilis - plėvele dengtos tabletės - 50 mg; 100 mg - sildenafil

Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

teva gmbh - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and sitagliptin

Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

teva b.v. - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and vildagliptin